Sign in

CIK 0001357874

  • Non-accelerated filer
  • Smaller reporting company

PRECISION BIOSCIENCES INC

Sign in to watch
Ticker
DTIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
May 21
Incorporated
DE
Entity type
Operating
Phone
+1 919-314-5512
Business address
302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
Open-market buys, last 90 days
$29,501
in 3 filings
Open-market sales, last 90 days
$27,505
in 1 filing, $28K under 10b5-1 plans

Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 39 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-05-07 KANE MATTHEW R. President and CEO Option exercise · Employee Stock Option (Right to Buy) −21,514 43,028
2021-04-21 KANE MATTHEW R. President and CEO Option exercise +13,422 $1.18 $16K 1,978,218
2021-04-21 KANE MATTHEW R. President and CEO Option exercise · Employee Stock Option (Right to Buy) −13,422 0
2021-04-19 JANTZ DEREK Chief Scientific Officer Option exercise +21,514 $0.04 $861 4,026,435
2021-04-19 JANTZ DEREK Chief Scientific Officer Sale −9,676 $8.69 $84K 4,016,759
2021-04-19 JANTZ DEREK Chief Scientific Officer Option exercise · Employee Stock Option (Right to Buy) −21,514 64,542
2021-04-16 JANTZ DEREK Chief Scientific Officer Option exercise +21,514 $0.04 $861 4,014,596
2021-04-16 JANTZ DEREK Chief Scientific Officer Sale −9,675 $8.84 $86K 4,004,921
2021-04-16 JANTZ DEREK Chief Scientific Officer Option exercise · Employee Stock Option (Right to Buy) −21,514 86,056
2021-04-15 JANTZ DEREK Chief Scientific Officer Option exercise +21,514 $0.04 $861 4,002,758
2021-04-15 JANTZ DEREK Chief Scientific Officer Sale −9,676 $8.76 $85K 3,993,082
2021-04-15 JANTZ DEREK Chief Scientific Officer Option exercise · Employee Stock Option (Right to Buy) −21,514 107,570
2021-04-12 KANE MATTHEW R. President and CEO Option exercise +21,514 $0.04 $861 1,974,537
2021-04-12 KANE MATTHEW R. President and CEO Sale −9,741 $8.67 $84K 1,964,796
2021-04-12 KANE MATTHEW R. President and CEO Option exercise · Employee Stock Option (Right to Buy) −21,514 64,542
2021-04-12 Frankel Stanley Director Grant or award · Stock Option (Right to Buy) +63,325 63,325
2021-04-09 KANE MATTHEW R. President and CEO Option exercise +21,514 $0.04 $861 1,962,760
2021-04-09 KANE MATTHEW R. President and CEO Sale −9,737 $8.87 $86K 1,953,023
2021-04-09 KANE MATTHEW R. President and CEO Option exercise · Employee Stock Option (Right to Buy) −21,514 86,056
2021-04-08 KANE MATTHEW R. President and CEO Option exercise +21,514 $0.04 $861 1,950,982

Page 21 of 23 · 456 trades